Therapeutics: Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)

Other

INDICATION: Progeria

Patient sample, cell culture and mouse studies suggest promoting NFE2L2 activity could help treat Hutchinson-Gilford progeria syndrome (HGPS). In patient fibroblasts, NFE2L2 activity

Read the full 243 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE